Cancer ratio test for malignant and tuberculous pleural effusions
Part of Cancer, Lungs & breathing clinical trials.
This study looks at a simple blood and fluid test to help tell the difference between cancer-related and tuberculosis-related fluid around the lungs. It might help doctors diagnose these conditions more accurately without more invasive procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have fluid around your lungs (pleural effusion).
- Your doctor must confirm the fluid is due to cancer or tuberculosis.
- You must have had certain lab tests done on your blood and fluid.
- You cannot have a mixed cause for the fluid (like both cancer and an infection).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares three ways to drain fluid that has built up around the lungs due to cancer. The goal is to find which method works best for relieving symptoms like shortness of breath.
This study compares two ways to stop fluid from building up again in the chest for people with cancer-related fluid buildup. One method uses a medicine called bleomycin, and the other uses a physical rubbing procedure during a scope exam. The goal is to help you breathe easier and improve your quality of life.
This trial tests a new drug called MT027 for people with advanced cancer that has spread to the lining around the lungs (pleura) and caused fluid buildup. The drug targets a marker on cancer cells called B7-H3. It may help control the fluid and the cancer.
This study looks at fluid from around the lungs (pleural fluid) to find gene changes (oncodrivers) in people with non-small cell lung cancer. The goal is to see if this fluid can replace a tissue biopsy for testing.
This study tests a two-medicine treatment (given through a chest tube) to help clear fluid around the lungs caused by TB or other infections. It aims to see if this treatment is safe and works well.
This trial tests whether a talc procedure to seal the lung (pleurodesis) can be done safely in an outpatient setting for people with fluid buildup from cancer. It aims to make the treatment more convenient.
Hear when a new Malignant Pleural Effusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.